Zhengang Qiu

Ganzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma.

Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma.

Journal: Translational oncology

Published: June 12, 2026

Multi-trait association analysis reveals shared genetic architecture between lung cancer and cardiometabolic diseases.

Multi-trait association analysis reveals shared genetic architecture between lung cancer and cardiometabolic diseases.

Journal: iScience

Published: July 10, 2025

Computational approaches to druggable site identification: Current status and future perspective.

Computational approaches to druggable site identification: Current status and future perspective.

Journal: Acta pharmaceutica Sinica. B

Published: June 14, 2025

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway.

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway.

Journal: Oncogene

Published: May 29, 2025

High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.

High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.

Journal: BMC cancer

Published: March 11, 2025

Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study.

Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study.

Journal: Frontiers in oncology

Published: December 14, 2024

Decoding the mechanisms behind second primary cancers.

Decoding the mechanisms behind second primary cancers.

Journal: Journal of translational medicine

Published: August 19, 2024

3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes.

3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes.

Journal: Radiation oncology (London, England)

Published: April 10, 2024

Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system.

Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system.

Journal: Clinical and experimental medicine

Published: March 31, 2024

Druggable targets for Parkinson's disease: transcriptomics based Mendelian randomization study.

Druggable targets for Parkinson's disease: transcriptomics based Mendelian randomization study.

Journal: Scientific reports

Published: February 19, 2024

Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.

Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.

Journal: Frontiers of medicine

Published: November 21, 2023

Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity.

Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity.

Journal: iScience

Published: September 24, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026